BUZZ-Australia's Island Pharmaceuticals rises on US patent for dengue drug

Reuters
11 Dec 2024
BUZZ-Australia's Island Pharmaceuticals rises on US patent for dengue drug

** Shares of Island Pharmaceuticals ILA.AX rise as much as 13.3% to A$0.170, their biggest intraday pct gain since Nov 27

** The drug company says the United States Patent and Trademark Office has granted a key patent for its drug ISLA-101

** Patent covers a method of reducing severity of one or more symptoms of dengue virus by administering ISLA-101 - co

** ILA stock up 89.5% YTD, as of 1204 GMT

(Reporting by Adwitiya Srivastava in Bengaluru)

((Adwitiya.Srivastava@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10